AstraZeneca Bolsters Cancer Treatment Capabilities With $1 Billion EsoBiotec Acquisition

by News Editor

March 17, 2025

The renowned British pharmaceutical company, AstraZeneca, has announced a striking move by acquiring Belgium’s EsoBiotec for an impressive sum of up to $1 billion. This acquisition is expected to significantly boost AstraZeneca’s expertise in cancer treatment formulations.

This ambitious move consists of an immediate payment of $425 million with the potential to invest an additional $575 million to meet developmental and regulatory milestones. This strategic acquisition fully supports AstraZeneca’s vision of revolutionizing cancer treatment through cutting-edge cellular therapy.

Follow THE FUTURE on LinkedIn, Facebook, Instagram, X and Telegram

EsoBiotec’s platform is renowned for its transformative approach to cellular therapy, aiming to enhance the body’s immune defenses against cancer cells. By engineering immune cells directly within the patient’s body utilizing targeted viruses, what once took weeks for treatment could now potentially be reduced to mere minutes—a groundbreaking leap in medical technology!

Following the conclusion of this deal by the second quarter of 2025, EsoBiotec will operate as a subsidiary under AstraZeneca, continuing its innovative work from Belgium. This move aligns seamlessly with AstraZeneca’s commitment to advancing healthcare and providing innovative solutions in the realm of oncology.

Furthering The Fight Against Cancer

On the same day, AstraZeneca also announced an agreement to license multiple oncology assets from Alteogen. Such strategic partnerships underscore AstraZeneca’s dedication to pioneering advances in cancer treatment.

For more insightful developments such as these, explore the latest Biobank.cy’s Nano-Innovation Sets A New Standard In Targeted Breast Cancer Treatment.

The Future Forbes Realty Global Properties

Central Bank Of Cyprus Reports €28 Billion In Total Assets And Liabilities

by THEFUTURE.TEAM

March 17, 2026

The Central Bank of Cyprus (CBC) today disclosed that its total assets and liabilities have reached €27.99 billion as of the end of February 2026. In a detailed balance sheet release, the bank outlined the composition of its portfolio, underscoring stronger intra-Eurosystem positioning and diversified liabilities.

Strategic Asset Allocation

The financial institution’s balance sheet revealed that intra-Eurosystem claims constituted the bulk of its assets, totaling €18.33 billion. Equally significant, the CBC’s holdings in gold and gold receivables were valued at €1.64 billion, reinforcing its traditional store-of-value strategy. Smaller segments include claims on residents outside the euro area denominated in foreign currency at €1.10 billion, compared with €0.59 billion in euro-denominated claims on the same group.

Follow THE FUTURE on LinkedIn, Facebook, Instagram, X and Telegram

Diverse Portfolio Components

Securities of euro area residents denominated in euros totaled €6.17 billion. Additional components included €0.02 billion in foreign currency claims on euro area residents and €0.14 billion classified as other assets. These figures reflect the distribution of assets across different categories.

Liabilities And Monetary Policy Operations

On the liabilities side, the CBC reported that monetary policy operations with credit institutions dominated, amounting to €17.12 billion. Additionally, the bank accounted for €3.22 billion in banknotes in circulation alongside €3.73 billion owed to the general government. Future risk provisions and revaluation accounts were maintained at €0.60 billion and €1.64 billion respectively, ensuring a buffer for volatility in evolving market conditions.

Capital And International Obligations

Capital and reserve holdings stood at €0.33 billion, supporting the institution’s ongoing financial solidity. Moreover, the bank recognized €0.49 billion as liabilities linked to the special drawing rights allocated by the International Monetary Fund, reflecting its engagements on the international stage.

Overall, the CBC’s comprehensive disclosure provides a clear roadmap of its asset allocation and liability management, reinforcing its role as a key pillar in the region’s financial stability.

Breaking news